Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.001 | 1 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |